MARX Biotech Co., Ltd.
MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.
Market Cap & Net Worth: MARX Biotech Co., Ltd. (7731)
MARX Biotech Co., Ltd. (TWO:7731) has a market capitalization of $82.67 Million (NT$2.74 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21184 globally and #1142 in its home market, demonstrating a -1.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MARX Biotech Co., Ltd.'s stock price NT$5.24 by its total outstanding shares 521980572 (521.98 Million).
MARX Biotech Co., Ltd. Market Cap History: 2026 to 2026
MARX Biotech Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $82.67 Million to $82.67 Million (0.00% CAGR).
MARX Biotech Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MARX Biotech Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7731 by Market Capitalization
Companies near MARX Biotech Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to MARX Biotech Co., Ltd. by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
MARX Biotech Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, MARX Biotech Co., Ltd.'s market cap moved from $82.67 Million to $ 82.67 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$82.67 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MARX Biotech Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $82.67 Million USD |
| MoneyControl | $82.67 Million USD |
| MarketWatch | $82.67 Million USD |
| marketcap.company | $82.67 Million USD |
| Reuters | $82.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.